RxDoctor Payments DataLook up a doctor →

Stephen Martino, MD

Neurology · Brick, NJNPI 1730161654

Payments from drug & device makers

$143,622in general payments, 2019–2025

Across 1,392 payments — averaging $103.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$71K
  • Janssen Research & Development, LLC$50K
  • Biogen$7K
  • Novartis$2K
  • Pfizer$1K
  • Biohaven Pharmaceutical Holding Company Ltd.$1K
  • plus $11K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)227$70,697
Janssen Research & Development, LLC26$50,328
Biogen35$6,711
Novartis203$2,476
Pfizer107$1,379
Biohaven Pharmaceutical Holding Company Ltd.37$1,065
Teva Pharmaceuticals USA, Inc.86$961
AstraZeneca(2 entities)57$949
Bristol Myers Squibb63$805
UCB, Inc.59$793
EMD Serono, Inc.52$728
Lilly USA, LLC41$613
Argenx US, Inc.29$417
SK Life Science, Inc.23$397
Eisai Inc.27$389
Amgen(2 entities)28$368
Lundbeck LLC23$336
Axsome Therapeutics, Inc.8$240
Neurelis, Inc.15$225
Neurocrine Biosciences, Inc.12$196
Amneal Pharmaceuticals LLC13$188
Kyowa Kirin, Inc.13$183
E.r. Squibb & Sons, L.L.C.14$178
CSL Behring8$154
Biohaven Pharmaceuticals, Inc.16$153
Johnson & Johnson10$144
Sanofi10$143
Otsuka America Pharmaceutical, Inc.7$137
Sumitomo Pharma America, Inc.12$130
Ipsen Biopharmaceuticals, Inc8$125
Genentech USA, Inc.8$122
Scilex Pharmaceuticals Inc.8$116
Grifols USA, LLC7$116
Mallinckrodt Hospital Products Inc.7$107
Supernus Pharmaceuticals, Inc.7$104
Currax Pharmaceuticals LLC7$102
Novocure Inc.1$97
Merz Pharmaceuticals, LLC5$82
Merz North America, Inc.4$81
Boston Scientific4$80
MDD US Operations, LLC4$69
Amylyx Pharmaceuticals, Inc.4$67
Takeda Pharmaceuticals U.S.A., Inc.4$60
Neuropace, Inc.1$59
Corium, LLC4$58
Avion Pharmaceuticals4$56
GE HealthCare3$53
Catalyst Pharmaceuticals, Inc.3$48
Nevro Corp.2$42
Avanir Pharmaceuticals, Inc.3$42
Acorda Therapeutics, Inc3$41
Life Molecular Imaging Ltd3$35
Acadia Pharmaceuticals Inc2$29
Upsher-smith Laboratories LLC2$27
Aucta Pharmaceuticals, Inc.2$25
Adamas Pharmaceuticals, Inc.2$24
Cycle Pharmaceuticals Inc1$18
Medtronic1$17
Revance Therapeutics, Inc.1$17
Vanda Pharmaceuticals Inc.1$16

How this compares

$143,622 in reported general payments places this provider in the 95th percentile of 521 neurology providers in New Jersey.

See all neurology providers in New Jersey →

Medicare billing

Part B allowed, 2024
$307,735
Medicare patients
999
Services billed
2,293

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Brick

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →